Clinical Trials in Quzhou, China

3 recruiting

Showing 19 of 9 trials

Recruiting
Phase 3

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Heart Failure and Impaired Kidney Function
AstraZeneca4,800 enrolled842 locationsNCT06307652
Recruiting
Phase 3

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Chronic Obstructive Pulmonary Disease
Sanofi942 enrolled150 locationsNCT07190222
Recruiting
Not Applicable

The Hi-tACS on Cognitive Function in Patients With Schizophrenia

Schizophrenia
Sir Run Run Shaw Hospital100 enrolled2 locationsNCT06470516
Recruiting
Not Applicable

High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients

Esophageal CancerHypoxiaGastric Cancer (Diagnosis)+1 more
Zhejiang University600 enrolled3 locationsNCT07307560
Recruiting
Phase 3

A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease

Crohn's Disease
Takeda408 enrolled41 locationsNCT05837897
Recruiting
Not Applicable

Clinical Study of the Pulsed Electric Field Ablation System in Chronic Obstructive Pulmonary Disease

COPD, Chronic Obstructive Pulmonary DiseaseChronic Bronchitis
Suzhou Hengruihongyuan Medical Technology Co. LTD210 enrolled13 locationsNCT07068438
Recruiting
Phase 2

Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma

Marginal Zone Lymphoma (MZL)
Second Affiliated Hospital, School of Medicine, Zhejiang University51 enrolled18 locationsNCT07022223
Recruiting
Phase 4

The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis

Ulcerative Colitis
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled12 locationsNCT06609447
Recruiting
Phase 2

Radiotherapy Combined With Endostatin and Capecitabine for NPC

Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital41 enrolled7 locationsNCT05514275